Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thrombocythemia, Essential × Watchful Waiting × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 3 Oropharyngeal Neoplasms 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Retinoblastoma 1 Pleuropulmonary blastoma 1 Pelvic Neoplasms 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Leukemia, Myeloid, Acute 1 Epstein-Barr Virus Infections 1 Endometrial Neoplasms 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Anus Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1 Anal Canal Carcinoma 1

Interventions

ruxolitinib 3 venetoclax 1 veliparib 1 pevonedistat 1 iadademstat 1 fedratinib 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 Topotecan 1 Specimen Handling 1 Injections 1 INCB057643 1 Decitabine 1 Carboplatin 1 Biopsy 1 Azacitidine 1 Acetylcysteine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡